Xylazine: What It Is, and Why It's Changing Overdose Response
Not an opioid. Not reversed by naloxone. Increasingly in the fentanyl supply — and leaving characteristic wounds.
Body: [Clear explainer: xylazine is a veterinary sedative (“tranq”), not a scheduled drug, appearing across the illicit opioid supply. Naloxone reverses the fentanyl component of an overdose but not the xylazine sedation — supportive breathing and 911 still required. The wound pattern is characteristic (necrotic ulcers unrelated to injection site). Test strip availability is expanding. Includes geographic spread data, treatment implications, and regulatory response. 900 words.]
Sources Cited
- 01.A
- 02.A
Filed Under
NaloxoneOverdosePeer-Reviewed Research
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Naloxone Still Reverses Fentanyl. It Doesn't Touch What's Being Cut Into It Now.
Nitazenes (up to 40x fentanyl's strength) have been confirmed in 48 of 50 states, and a veterinary sedative called medetomidine is spreading through the fentanyl supply. Naloxone doesn't fully reverse either one. Here's what actually changes for harm reduction.
Harm ReductionXylazine Was the Adulterant Everyone Learned to Test For. Medetomidine Is 300 Times Stronger, and the Government Just Defunded the Strips That Catch It
Medetomidine, a veterinary sedative up to 300 times more potent than xylazine, is displacing tranq in the fentanyl supply. Here's the science, the scheduling fight, and why test strips matter more than ever.
Harm ReductionSubstance Spotlight: Inhalants Are the Overdose Crisis Nobody Is Watching, and It's Getting Younger
2024 NSDUH data shows 3.2 million Americans used inhalants in the past year, with teen rates far outpacing adults. A wave of 2026 state legislation targets flavored nitrous oxide products like Galaxy Gas.